课题基金 / 基金详情

The molecular role of lkaros in leukemogenesis

The molecular role of lkaros in leukemogenesis
lkaros 在白血病发生中的分子作用
批准号:
7102471
负责人:
SUSAN M WINANDY
金额:
$20.69万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-04-01 至 2010-02-28

项目摘要

项目成果

SUSAN M WINANDY的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):肿瘤抑制基因是一组基因,其功能经常通过突变癌细胞而丧失。我们已经确定Ikaros作为一种新的T细胞系特异性肿瘤抑制蛋白的特征。在100%的转化率下,小鼠中缺乏Ikaros活性导致白血病发生。我们已经表明,使用一种新的细胞培养系统,Ikaros的基因恢复到Ikaros无效T白血病细胞系的细胞周期停滞和启动的T细胞特异性的基因表达程序的结果。我们还确定了细胞周期调节因子p27 kip 1作为Ikaros转录激活的潜在遗传靶点。有趣的是,p27 kip 1基因表达水平的降低与Bcr/Abl诱导的人类白血病的机制有关,这表明Ikaros null T细胞中p27 kip 1水平的降低可能是其显著转化倾向的关键。Ikaros也可能在人类细胞中发挥肿瘤抑制作用,因为分析的婴儿和儿童急性淋巴细胞白血病中有很高比例显示Ikaros基因表达缺陷。本提案中描述的实验的目的是确定缺乏Ikaros活性导致白血病发生的机制。为此,我们将:1)鉴定Ikaros在生长控制中的作用所必需的功能/相互作用结构域,2)确定Ikaros控制p27 kip 1基因表达的机制,和3)鉴定Ikaros在启动T细胞特异性基因表达程序中的作用所需的功能/相互作用结构域。这些研究还将包括分析Ikaros与Brg-1和Swi/Snf染色质重塑复合物在T细胞生长控制和诱导T细胞特异性基因表达程序中的作用。定义Ikaros功能机制的困难至少部分是由于缺乏易于操作的实验系统。然而,我们独特的细胞培养系统组成的Ikaros空T白血病细胞系,可以使用逆转录病毒转导基因改变是一个有效的工具来定义Ikaros功能的机制。这个系统,结合Ikaros无效小鼠,使我们唯一有资格定义这种新的肿瘤抑制基因的机制作用。
英文摘要
DESCRIPTION (provided by applicant): Tumor suppressor genes are a group of genes whose function is frequently lost through mutation cancer cells. We have identified Ikaros as a protein with characteristics of a novel T lineage specific tumor suppressor. With 100% penetrance, lack of Ikaros activity in mice results in leukemogenesis. We have shown, using a novel cell culture system, that genetic restoration of Ikaros to an Ikaros null T leukemia cell line results in cell cycle arrest and initiation of a T cell specific program of gene expression. We have also identified the cell cycle regulator, p27kip1, as a potential genetic target for transcriptional activation by Ikaros. Interestingly, decreased levels of p27kip1 gene expression have been linked to the mechanism of Bcr/Abl induced human leukemia, suggesting that decreased p27kip1 levels in Ikaros null T cells may hold the key to their remarkable propensity to transform. Ikaros may play a tumor suppressive role in human cells as well, since a high percentage of analyzed infant and childhood acute lymphocytic leukemias display defects in Ikaros gene expression. The goal of the experiments described in this proposal is to define mechanisms by which lack of Ikaros activity leads to leukemogenesis. We will do this by: 1) identifying Ikaros' functional/interaction domains essential to its role in growth control, 2) defining the mechanism by which Ikaros controls expression of the p27kip1 gene and 3) identifying Ikaros' functional/interaction domains required for its role in initiating a T cell specific program of gene expression. These studies will also include analyses of the role of Ikaros' association with Brg-1 and the Swi/Snf chromatin remodeling complexes in T cell growth control and induction of a T cell specific program of gene expression. The difficulty in defining mechanisms of Ikaros function has been due, at least in part, to lack of an easily manipulated experimental system. However, our unique cell culture system consisting of an Ikaros null T leukemia cell line that can be genetically altered using retroviral transduction is a potent tool to define mechanisms of Ikaros function. This system, in conjunction with the Ikaros null mice, makes us uniquely qualified to define the mechanistic role of this novel tumor suppressor gene.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanism of Notch-induced leukemogenesis in lymphocytes
  • 批准号:
    8637293
  • 项目类别:
  • 资助金额:
    $22.63万
  • 财政年份:
    2014
  • 负责人:
    SUSAN M WINANDY
  • 依托单位:
Mechanism of Notch-induced leukemogenesis in lymphocytes
  • 批准号:
    8777092
  • 项目类别:
  • 资助金额:
    $17.8万
  • 财政年份:
    2014
  • 负责人:
    SUSAN M WINANDY
  • 依托单位:
Generation of Ikaros conditional knockout mice
  • 批准号:
    8190587
  • 项目类别:
  • 资助金额:
    $8.18万
  • 财政年份:
    2011
  • 负责人:
    SUSAN M WINANDY
  • 依托单位:
Generation of Ikaros conditional knockout mice
  • 批准号:
    8304198
  • 项目类别:
  • 资助金额:
    $8.18万
  • 财政年份:
    2011
  • 负责人:
    SUSAN M WINANDY
  • 依托单位:
国内基金
海外基金
海马神经元胆固醇代谢重编程致染色质组蛋白乙酰化水平降低介导老年小鼠术后认知功能障碍
  • 批准号:
    82371192
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    田婕
  • 依托单位:
HK2乳酰化修饰介导巨噬细胞功能障碍在脓毒症中的作用及机制
  • 批准号:
    82372160
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    陈峰
  • 依托单位:
组蛋白乙酰化修饰ATG13激活自噬在牵张应力介导骨缝Gli1+干细胞成骨中的机制研究
  • 批准号:
    82370988
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    经典
  • 依托单位: